| Dr Lashonda Michele Dupont, PHARMD | |
|
137 Main St S, Allendale, SC 29810-3601 | |
| (803) 584-7735 | |
| (803) 584-0174 |
| Full Name | Dr Lashonda Michele Dupont |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 137 Main St S, Allendale, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487952685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10673 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lashonda Michele Dupont, PHARMD 2255 Appleton Rd, Allendale, SC 29810-6907 Ph: (803) 686-0589 | Dr Lashonda Michele Dupont, PHARMD 137 Main St S, Allendale, SC 29810-3601 Ph: (803) 584-7735 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
Adam Dicker, M.D., Ph.D., associate professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University and Jefferson's Kimmel Cancer Center in Philadelphia, Mary Frances McAleer, M.D., Ph.D., a resident in the Department of Radiation Oncology at Jefferson Medical College and their co-workers compared the effects on zebrafish embryos of two types of radiation – ionizing radiation, which is the kind given to patients for cancer treatment, and ultraviolet (UV) radiation, which comes naturally from the sun.
With the help of mouse models, induced pluripotent stem cells (iPSCs) and the "tooth fairy," researchers at the University of California, San Diego School of Medicine have implicated a new gene in idiopathic or non-syndromic autism. The gene is associated with Rett syndrome, a syndromic form of autism, suggesting that different types of autism spectrum disorder (ASD) may share similar molecular pathways.
The Moderna SARS-CoV-2 vaccine was widely distributed and had a reported efficacy in clinical trials of 94.1% against the wildtype SARS-CoV-2 following the second dose administration. Therefore, Chemaitelly et al. used this as an opportunity to measure the vaccine's efficacy against these variants as reported in a recent Nature Medicine paper, finding that the vaccine has good efficacy in all aspects.
BioClinica™, Inc.,, a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
› Verified 3 days ago
Mr. Donald Arthur Webster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 137 Main St S, Allendale, SC 29810 Phone: 803-584-2151 Fax: 803-584-0174 |